We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+8.35%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$116B
AUM Growth
+$12.3B
Cap. Flow
-$2.57B
Cap. Flow %
-2.21%
Top 10 Hldgs %
9.91%
Holding
5,208
New
1,193
Increased
1,491
Reduced
1,580
Closed
489

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$672M
2
MRK icon
Merck
MRK
+$476M
3
META icon
Meta Platforms (Facebook)
META
+$392M
4
MCD icon
McDonald's
MCD
+$372M
5
WFC icon
Wells Fargo
WFC
+$357M

Sector Composition

Rank Sector Weight
1 Technology 15.62%
2 Consumer Discretionary 9.84%
3 Healthcare 7.45%
4 Communication Services 7.19%
5 Financials 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WDH
4401
Waterdrop
WDH
$402M
$87K ﹤0.01%
+13,417
New +$102K
WPCB.WS
4402
DELISTED
Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WPCB.WS
$87K ﹤0.01%
+66,666
New +$75K
CENHW
4403
DELISTED
Centricus Acquisition Corp. Warrant
CENHW
$87K ﹤0.01%
+62,500
New +$66.3K
HMY icon
4404
Harmony Gold Mining
HMY
$9.92B
$86K ﹤0.01%
22,984
+1,630
+8% +$7.74K
AMPE
4405
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$86K ﹤0.01%
+172
New +$92.4K
LCAAW
4406
DELISTED
L Catterton Asia Acquisition Corp Warrant
LCAAW
$83K ﹤0.01%
+92,261
New +$79.9K
HERAW
4407
DELISTED
FTAC Hera Acquisition Corp. Warrant
HERAW
$82K ﹤0.01%
+61,792
New +$66.7K
AAQC.WS
4408
DELISTED
Accelerate Acquisition Corp Warrants
AAQC.WS
$82K ﹤0.01%
+66,666
New +$67.3K
TYME
4409
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$82K ﹤0.01%
64,965
+51,807
+394% +$74.7K
KSMTW
4410
DELISTED
Kismet Acquisition One Corp Warrant
KSMTW
$82K ﹤0.01%
75,000
BNGO icon
4411
Bionano Genomics
BNGO
$12.7M
$81K ﹤0.01%
+18
New +$71.1K
NGC.WS
4412
DELISTED
Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share
NGC.WS
$81K ﹤0.01%
+56,303
New +$64.9K
DGNR.WS
4413
DELISTED
Dragoneer Growth Opportunities Corp. Redeemable warrants, each whole warrant exercisable for one Cla
DGNR.WS
$80K ﹤0.01%
40,000
GAU
4414
Galiano Gold
GAU
$486M
$79K ﹤0.01%
72,458
+48,803
+206% +$59.3K
KLDO
4415
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$78K ﹤0.01%
+10,483
New +$74.3K
ASXC
4416
DELISTED
Asensus Surgical, Inc.
ASXC
$77K ﹤0.01%
+24,232
New +$60.6K
SCAQW
4417
DELISTED
Stratim Cloud Acquisition Corp. Warrant
SCAQW
$77K ﹤0.01%
+92,261
New +$70.2K
ATHN.WS
4418
DELISTED
Athena Technology Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one shar
ATHN.WS
$77K ﹤0.01%
+88,888
New +$67.2K
FOA icon
4419
Finance of America Companies
FOA
$204M
$76K ﹤0.01%
+1,000
New +$96.8K
SMMT icon
4420
Summit Therapeutics
SMMT
$10.9B
$76K ﹤0.01%
+10,162
New +$66.7K
APGB.WS
4421
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$76K ﹤0.01%
+60,000
New +$64.5K
TRCA.WS
4422
DELISTED
Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
TRCA.WS
$76K ﹤0.01%
+83,333
New +$62K
OTLK icon
4423
Outlook Therapeutics
OTLK
$263M
$75K ﹤0.01%
+1,507
New +$69.9K
NBSTW
4424
DELISTED
Newbury Street Acquisition Corporation Warrants
NBSTW
$74K ﹤0.01%
+100,000
New +$60K
NBEV
4425
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$73K ﹤0.01%
+32,519
New +$75.8K

Similar funds

D.E. Shaw & Co's Q2 2021 Portfolio in Review

As of Q2 2021, D.E. Shaw & Co held 5,208 positions worth $116B, up 12% from $104B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

D.E. Shaw & Co's Q2 2021 filing shows 1,193 new, 1,491 increased, 1,580 reduced and 489 closed positions. Its largest new stake was Weatherford International: 4,894,906 shares worth $89.1M. The largest sale was Microsoft, an estimated $672M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • D.E. Shaw & Co's largest Q2 2021 buy was Weatherford International: 4,894,906 shares worth $89.1M.
  • D.E. Shaw & Co added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $700M increase.
  • D.E. Shaw & Co's biggest Q2 2021 reduction was Microsoft, cutting an estimated $672M.
  • D.E. Shaw & Co fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $131M.
  • D.E. Shaw & Co's ten largest holdings make up 9.9% of its $116B portfolio in Q2 2021.
  • D.E. Shaw & Co opened 1,193 new positions and closed 489 in Q2 2021.
  • D.E. Shaw & Co's portfolio value rose 12% quarter-over-quarter to $116B.

Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.